#Neuraminidase #inhibitors for #ILI in primary care (Lancet, summary)

[Source: The Lancet, full page: (LINK). Summary, edited.]

Neuraminidase inhibitors for influenza-like illness in primary care

Nelson Lee, Michael Ison

Published: December 12, 2019 / DOI: https://doi.org/10.1016/S0140-6736(19)33097-1


Primary care physicians have an important role in managing most of the influenza cases during seasonal epidemics. Symptomatic treatment and antibiotics are commonly prescribed due to undifferentiated manifestations of acute respiratory infections. Neuraminidase inhibitor treatment is recommended in outpatients if they have severe symptoms or are at risk for complications and present within 2 days of illness. 1
However, global use of neuraminidase inhibitor treatment is low. 2
Concerns about the modest benefits and side-effects of neuraminidase inhibitors and inaccessibility to rapid, sensitive influenza diagnostics might have reduced broader use of this treatment.


Keywords: Seasonal Influenza; Antivirals; Oseltamivir.


Published by

Giuseppe Michieli

I am an Italian blogger, active since 2005 with main focus on emerging infectious diseases such as avian influenza, SARS, antibiotics resistance, and many other global Health issues. Other fields of interest are: climate change, global warming, geological and biological sciences. My activity consists mainly in collection and analysis of news, public services updates, confronting sources and making decision about what are the 'signals' of an impending crisis (an outbreak, for example). When a signal is detected, I follow traces during the entire course of an event. I started in 2005 my blog ''A TIME'S MEMORY'', now with more than 40,000 posts and 3 millions of web interactions. Subsequently I added an Italian Language blog, then discontinued because of very low traffic and interest. I contributed for seven years to a public forum (FluTrackers.com) in the midst of the Ebola epidemic in West Africa in 2014, I left the site to continue alone my data tracking job.